AArtificial intelligence Read More Jamie Dimon makes huge call on AI and U.S. economyAugust 7, 2026 AI CapEx fatigue continues to sour investors as hyperscalers shell out billions on data centers, chips, and power…
AArtificial intelligence Read More Mark Zuckerberg Says He’s Betting Big on AI Compute Even as Meta’s Free Cash Flow Craters. Here’s What Investors Should Watch.August 2, 2026 Shares of Meta Platforms (NASDAQ: META) are down about 16% year to date as investors focus on the…
AArtificial intelligence Read More Rockefeller CIO Warns: Big Tech’s $650B AI Buildout May Be Hiding a Massive OverbuildJuly 24, 2026 Quick Read Microsoft targets $190B and Amazon $200B in 2026 AI CapEx, with Amazon’s free cash flow already…
AArtificial intelligence Read More Oracle’s Credit Risk Nears an 18-Year High: Can AI Backlog Save Stock?July 21, 2026 Credit rating agencies have grown increasingly cautious on Oracle ORCL as the company’s aggressive artificial intelligence buildout strains…
AArtificial intelligence Read More Big Tech is paying for the AI boom, and chipmakers are cashing in: Chart of the DayJuly 11, 2026 Wall Street knows Big Tech can spend on artificial intelligence. The harder question is how quickly that spending…
AArtificial intelligence Read More Apollo’s Sløk: The market faces big risks if hyperscalers’ AI profits get delayedJuly 9, 2026 Wall Street expects hyperscaler companies’ free cash flow to boom, starting in 2028. If that boom doesn’t materialize,…
HHealthcare Read More 2 Dirt Cheap Healthcare Stocks to Buy in JulyJuly 8, 2026 Quick Read NVO trades at a forward P/E of 14 and PFE at just 8x, making both the…
PPersonal finance Read More This 7% Yielding Healthcare Powerhouse Belongs in Retirees’ PortfoliosJune 30, 2026 Quick Read PFE’s 7.27% yield looks safe on a 53% adjusted payout ratio, but free cash flow fell…
HHealthcare Read More Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?June 28, 2026 Choosing between established healthcare giants often comes down to balancing income needs against growth potential. Both Bristol Myers…
PPersonal finance Read More 64 Years Old With $1.1 Million in a Traditional IRA. Here’s Where I’m Allocating CapitalJune 25, 2026 Quick Read KO and ABBV anchor the portfolio at 25% each, rated Very Safe with payout ratios under…
GGadgets Read More 2 Reasons to Watch IONQ and 1 to Stay CautiousJune 23, 2026 Since December 2025, IonQ has been in a holding pattern, posting a small return of 4% while floating…
HHealthcare Read More 2 Healthcare Stocks with Exciting Potential and 1 Facing ChallengesMay 29, 2026 Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has…